HLB Life Science Co., Ltd.
067630.KQ
Price:
$3685
Market Cap:
$449.01B
HLB Life Science Co., Ltd. engages in the wholesaling and distribution of pharmaceuticals in South Korea and internationally. It also develops Rivoceranib, a small-molecule tyrosine kinase inhibitor for the treatment of various cancers, including gastric cancer, colorectal cancer, hepatocellular carcinoma, non-small cell lung cancer, esophageal cancer, thyroid cancer, mesothelioma, and neuroendocrine tumors; Seclidemstat, a novel epigenetic oral small molecule for target therapy to normalize gene expression and suppress tumor growth in various solid tumors, such as lung, breast, and prostate cancer; and Tegavivint, inhibitor of the Wnt/β-catenin for the treatment of desmoid tumors, acute mye...[Read more]
Industry
Renewable Utilities
IPO Date
2008-11-25
Stock Exchange
KOE
Ticker
067630.KQ
PE Ratio
[-7.89]
ROE
[-53.64%]
Current Ratio
[0.93]
Dividend Yield
[0%]
Enterprise Value
[579.16B]
Dividend History
The Current Ratio as of December 2025 (TTM) for HLB Life Science Co., Ltd. (067630.KQ) is 0.93
According to HLB Life Science Co., Ltd.’s latest financial reports and current stock price. The company's current Current Ratio is 0.93. This represents a change of -53.35% compared to the average of 2.00 of the last 4 quarters.
HLB Life Science Co., Ltd. (067630.KQ) Historical Current Ratio (quarterly & annually)
How has 067630.KQ Current Ratio performed in the past?
The mean historical Current Ratio of HLB Life Science Co., Ltd. over the last ten years is 4.80. The current 0.93 Current Ratio has changed 1.85% with respect to the historical average. Over the past ten years (40 quarters), 067630.KQ's Current Ratio was at its highest in in the September 2021 quarter at 28.45. The Current Ratio was at its lowest in in the September 2025 quarter at 0.93.
Average
4.80
Median
3.91
Minimum
1.09
Maximum
11.59
HLB Life Science Co., Ltd. (067630.KQ) Current Ratio by Quarter and Year
Discovering the peaks and valleys of HLB Life Science Co., Ltd. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 167.16%
Maximum Annual Current Ratio = 11.59
Minimum Annual Increase = -81.92%
Minimum Annual Current Ratio = 1.09
| Year | Current Ratio | Change |
|---|---|---|
| 2024 | 2.90 | 167.16% |
| 2023 | 1.09 | -81.92% |
| 2022 | 6.00 | -48.19% |
| 2021 | 11.59 | 14.15% |
| 2020 | 10.15 | 80.81% |
| 2019 | 5.61 | 14.20% |
| 2018 | 4.92 | 141.32% |
| 2017 | 2.04 | 36.09% |
| 2016 | 1.50 | -32.06% |
| 2015 | 2.20 | 96.00% |
HLB Life Science Co., Ltd. (067630.KQ) Average Current Ratio
How has 067630.KQ Current Ratio performed in the past?
The current Current Ratio of HLB Life Science Co., Ltd. (067630.KQ) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
3.33
5-year avg
6.34
10-year avg
4.80
HLB Life Science Co., Ltd. (067630.KQ) Current Ratio vs. Peers
How is 067630.KQ’s Current Ratio compared to its peers?
HLB Life Science Co., Ltd.’s Current Ratio is greater than SGC Energy Co.,Ltd. (0.75), less than Samchully Co.,Ltd (1.44), less than Korea Electric Power Industrial Development Co., Ltd (2.03), greater than APTN Inc. (0.73), less than INVENI Co., Ltd. (14.87), greater than Daesung Energy Co., Ltd. (0.90), less than Seoul City Gas Co., Ltd. (3.52), less than Daesung Holdings Co., Ltd. (1.63), less than Kyungdong Invest Co., Ltd (3.44), less than Kyungdong City Gas Co., Ltd (1.63),
| Company | Current Ratio | Market cap |
|---|---|---|
| 0.75 | $345.77B | |
| 1.44 | $445.12B | |
| 2.03 | $350.78B | |
| 0.73 | $71.68B | |
| 14.87 | $291.11B | |
| 0.90 | $220.28B | |
| 3.52 | $259.56B | |
| 1.63 | $144.37B | |
| 3.44 | $114.47B | |
| 1.63 | $129.00B |
Build a custom stock screener for HLB Life Science Co., Ltd. (067630.KQ) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like HLB Life Science Co., Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
HLB Life Science Co., Ltd. (067630.KQ) and other stocks custom spreadsheet templates
The easiest way to analyze a company like HLB Life Science Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the Current Ratio?
How can you use the Current Ratio?
What is HLB Life Science Co., Ltd.'s Current Ratio?
How is the Current Ratio calculated for HLB Life Science Co., Ltd. (067630.KQ)?
What is the highest Current Ratio for HLB Life Science Co., Ltd. (067630.KQ)?
What is the 3-year average Current Ratio for HLB Life Science Co., Ltd. (067630.KQ)?
What is the 5-year average Current Ratio for HLB Life Science Co., Ltd. (067630.KQ)?
How does the current Current Ratio for HLB Life Science Co., Ltd. (067630.KQ) compare to its historical average?